Koyfin Home > Directory > Health Care > American Renal Associates > Total Debt / EBITDA

American Renal Associates Total Debt / EBITDA Chart (ARA)

American Renal Associates annual/quarterly Total Debt / EBITDA from 2010 to 2020.
  • American Renal Associates Total Debt / EBITDA for the quarter ending September 09, 2020 was $4m a -19.85% decrease of -1m year over year
  • American Renal Associates Total Debt / EBITDA for the last 12 months ending September 09, 2020 was $5m a 1.71% increase of 0m year over year
  • American Renal Associates Annual Total Debt / EBITDA for 2019 was $5m a 8.52% increase of 0m from 2018
  • American Renal Associates Annual Total Debt / EBITDA for 2018 was $4m a 6.82% increase of 0m from 2017
  • American Renal Associates Annual Total Debt / EBITDA for 2017 was $4m a 21.78% increase of 1m from 2016
Other Ratios Metrics:
  • American Renal Associates Total Debt / Capital for the quarter ending September 09, 2018 was $70m a 1.83% increase of 1m year over year
  • American Renal Associates Other Liabilities for the quarter ending September 09, 2018 was $39m a 19.44% increase of 8m year over year
  • American Renal Associates Total Debt / Equity for the quarter ending September 09, 2018 was $228m a 5.77% increase of 13m year over year
View Chart On Koyfin

Quarterly ARA Total Debt / EBITDA Data

09/2020$4m
06/2020$4m
03/2020$8m
12/2019$5m
09/2019$4m
06/2019$4m
03/2019$7m
12/2018$4m
09/2018$4m
06/2018$4m

Annual ARA Total Debt / EBITDA Data

2019$5m
2018$4m
2017$4m
2016$3m
2015$4m
2014$4m
2013$5m
2012$3m
2011$4m
2010$3m